^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    CCL7 overexpression

    i
    Other names: CCL7, FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7, Chemokine (C-C motif) ligand 7, Monocyte chemotactic protein 3
    Entrez ID:
    6354
    Related biomarkers:
    Expression
    Associations

    News

    Trials
    4years
    Association of CC chemokines with breast cancer disparity (AACR 2022)
    Furthermore, higher CCR9 expressing cells showed poor response to Carboplatin upon CCR9 activation. In conclusion, our data suggest the association of distinct CC-chemokines in BrCa progression, OS, and disparate disease outcome in AA compared to EA patients implying CCR9 signaling to be a potential target for improving chemotherapeutic response.
    BRCA Biomarker
    |
    HER-2 (Human epidermal growth factor receptor 2) • CCL20 (C-C Motif Chemokine Ligand 20) • CCL5 (Chemokine (C-C motif) ligand 5) • CCL11 (C-C Motif Chemokine Ligand 11) • CCL2 (Chemokine (C-C motif) ligand 2) • CCL22 (C-C Motif Chemokine Ligand 22) • CCL7 (Chemokine (C-C motif) ligand 7)
    |
    HER-2 expression • CCL5 overexpression • CCL7 expression • CCL7 overexpression
    |
    carboplatin